Previous Article |
Table of Contents
| Next Article
* Laboratories of Molecular Biophysics and
In eukaryotes, RNA polymerase II transcribes messenger RNAs and
several small nuclear RNAs. Like RNA polymerases I and III, polymerase
II cannot act alone. Instead, general initiation factors [transcription factor (TF) IIB, TFIID, TFIIE, TFIIF, and TFIIH] assemble on promoter DNA with polymerase II, creating a large multiprotein-DNA complex that supports accurate initiation. Another group of accessory factors, transcriptional activators and
coactivators, regulate the rate of RNA synthesis from each gene in
response to various developmental and environmental signals. Our
current knowledge of this complex macromolecular machinery is reviewed in detail, with particular emphasis on insights gained from structural studies of transcription factors.
Eukaryotic RNA polymerase II (pol II) is a 12-subunit
DNA-dependent RNA polymerase that is responsible for transcribing
nuclear genes encoding messenger RNAs and several small nuclear RNAs
(1). Despite its obvious structural complexity, this multisubunit
enzyme requires two groups of auxiliary proteins to solve two critical biochemical problems. First, pol II cannot recognize its target promoters directly. Second, pol II must be able to modulate production of the RNA transcripts of individual genes in response to developmental and environmental signals.
Promoter Anatomy and the Preinitiation Complex (PIC)
Class II nuclear gene promoters contain combinations of DNA
sequences, which include core or basal promoter elements, promoter proximal elements, and distal enhancer elements. Transcription initiation by pol II is precisely regulated by transcription factors (proteins) that interact with these three classes of DNA targets and
also with each other (reviewed in refs. 2-4). The best characterized core promoter elements, which can function independently or
synergistically, are the TATA element (located 25 bp upstream of the
transcription start site with consensus sequence TATAa/tAa/t), and
a pyrimidine-rich initiator element (located at the start site). The
core promoter constitutes the principal DNA target for pol II, and
accurate initiation of transcription depends on assembling pol II and
transcription factors (TFs) IID, IIB, IIF, IIE, and IIH into a PIC
(Table 1; Fig. 1). It is
believed that these transcription factors are required to position pol
II on most class II nuclear gene promoters, and they are usually
referred to as general initiation factors (reviewed in ref. 2). Thus,
the PIC is functionally equivalent to the much simpler
Escherichia coli holoenzyme, which is composed of the core
RNA polymerase subunits and a Table 1.
General class II transcription initiation factors from
human cells
Transcription Factor IID
In the most general case, messenger RNA production begins with
TFIID recognizing and binding tightly to the TATA element (Fig. 1).
TFIID's critical role has made it the focus of considerable biochemical and genetic study since its discovery in human cells in
1980 (7). Our current census of cloned TFIID subunits includes more
than a dozen distinct polypeptides, ranging in mass from 15 to 250 kDa
(reviewed in ref. 8). The majority of these TFIID subunits display
significant conservation among human, Drosophila, and yeast,
implying a common ancestral TFIID, and gene disruption studies of four
yeast TFIID subunits revealed that they are essential for viability (9,
10).
DNA binding by human TFIID was first demonstrated with the adenovirus
major late promoter (AdMLP) (11). DNase I footprinting studies of the
AdMLP and selected human gene promoters revealed sequence-specific
interactions between human TFIID and the TATA element, which are
primarily mediated by the TBP subunit of TFIID (see below). In
contrast, protection both upstream and downstream of the TATA element
is largely sequence independent, displays a nucleosome-like pattern of
DNase I hypersensitivity, varies radically between promoters, and can
be induced by some activators (reviewed in ref. 8). It is remarkable
that TATA box binding by either TFIID or TBP precludes packaging of the
core promoter with the nonlinker histone proteins (H2A, H2B, H3, and
H4). Conversely, core promoter packaging by histone octamers into
nucleosomes prevents TFIID or TBP binding to the TATA element,
effectively repressing transcription (reviewed in ref. 12). In
vivo, chromatin-mediated transcriptional repression is overcome by
various ATP-dependent macromolecular machines (e.g., the SWI/SNF
complex) that remodel chromatin in the vicinity of the core promoter
(reviewed in ref. 13).
TATA Box-Binding Protein
Publication of the sequence of yeast TBP in 1989 was followed
rapidly by the sequences of homologous genes from various eukaryotes and an archaebacterium (amino acid identities within the
phylogenetically conserved 180 residue portion range between 38% and
100%, reviewed in ref. 14). Recombinant TBP alone can bind both
general and regulatory factors and direct PIC assembly in
vitro and basal transcription (reviewed in ref. 2). Basal or core
promoter-dependent transcription is a relatively inefficient in
vitro reaction that has served as an important tool for
characterizing pol II's minimal requirement for TBP, TFIIB, TFIIF,
TFIIE, and TFIIH and the core region of the promoter immediately
upstream of the transcription start site. In addition to defining the
minimal factors required for accurate pol II initiation, the basal
transcription system has been used to establish the order of PIC
assembly depicted in Fig. 1A.
Fig. 1B contrasts basal and activated transcription
(reviewed in ref. 8). Activated transcription in vivo
requires the entire promoter, which includes the core region plus
promoter proximal and distal enhancer regions. Transcriptional
activators regulate the efficiency of pol II initiation by recognizing
their target DNA sequences within promoter proximal or distal enhancer elements and interacting with the PIC (possibly via intermediaries known as coactivators). Activated transcription requires TBP
and the remaining subunits of TFIID (the
TAFIIs), the other general initiation factors TFIIB, TFIIF,
TFIIE, and TFIIH, plus transcriptional activators and coactivators.
The three-dimensional structure of the conserved portion of TBP is
strikingly similar to a saddle (14-16) (Fig.
2A), which correlates perfectly with
TBP's biochemical function as a protein that sits on DNA creating a
stable platform for binding other transcription factors. DNA binding is
supported by the concave underside of the saddle, while the convex
upper surface or seat of the saddle binds various components of the
transcription machinery (reviewed in ref. 14). TBP consists of two
quasi-identical domains (Fig. 2A), corresponding to
the two direct repeats found in the conserved portion of TBP (15).
TBP's ancestor may, therefore, have functioned as a dimer, with gene
duplication and fusion giving rise to a monomeric, quasisymmetric TBP.
Structures of plant (17, 25), yeast (18), and human (19) TBPs complexed
with various TATA elements have also been determined (Fig.
2A). These three cocrystal structures are very similar and demonstrate a common induced-fit mechanism (26) of
protein-DNA recognition (G. Patikoglou, J. L. Kim, and S.K.B., unpublished data). DNA binding is mediated by the curved, antiparallel DNA packaging into nucleosomes involves wrapping a double helix around
the histone octamer. Sequence-dependent nucleosome positioning
correlates with bending A+T-rich sequences toward the minor groove (28,
29), and packaging of TATA elements into nucleosomes probably results
in minor groove compression precluding TBP binding. Conversely, a
preformed PIC remains transcriptionally active after nucleosome
assembly (30), and recombinant yeast TBP alone prevents
nucleosome-mediated repression of transcription (31). Thus, the
cocrystal structures of the TBP-DNA complexes may provide a simple
mechanical explanation for the mutual exclusion of DNA packaging and
transcription. It is widely believed that transcriptional activators
bound to promoter proximal and/or distal enhancer elements target
nucleosome-remodeling factors to the core promoters of genes slated for
expression. Once chromatin has been remodeled, TFIID would be able to
recognize the TATA element and begin PIC assembly (reviewed in ref.
32).
DNA deformation by TBP may also be important for coordinating and/or
stabilizing PIC assembly and activator-PIC interactions. PIC assembly
around a bend could produce a more compact multiprotein-DNA complex.
Moreover, DNA bending by TBP could aid in the looping of DNA to bring
remotely bound transcriptional activators closer to the core promoter
for interactions with components of the PIC.
Complementary biophysical methods have been used to study interactions
between TBP and DNA. Site-selection experiments with Acanthamoeba TBP showed a marked preference for a site very
similar to those studied crystallographically (33). DNA bending by TBP in solution was confirmed using circular permutation assays (34). TBP
binding was also shown to be enhanced by prebending of DNA toward the
major groove, and inhibited by prebending toward the minor groove (35).
TBP-DNA association kinetics have been studied by various techniques
(36-38), which gave results consistent with formation of an initial
collision complex followed by a slow isomerization step with a
second-order rate constant of about 106
M Transcription Factor IIB
TFIIB is the next general initiation factor to enter the PIC. The
resulting TFIIB-TFIID-DNA platform is in turn recognized by a complex
of pol II and TFIIF, followed by TFIIE and TFIIH (Fig. 1). In
vitro studies with a negatively supercoiled immunoglobulin gene
promoter demonstrated that accurate transcription initiation can be
reconstituted with TBP, TFIIB, and pol II, suggesting that together TBP
and TFIIB position pol II (40). Presumably, the energy provided by
negative supercoiling contributes to promoter melting at the
transcription start site, which is normally facilitated by the
ATP-dependent DNA helicase subunit of TFIIH (see below). Mutations in
TFIIB alter pol II start sites in yeast, as do mutations in the large
subunit of pol II, providing compelling evidence for its function as a
precise spacer/bridge between TFIID and pol II on the core promoter
that determines the transcription start site (reviewed in ref. 20).
The second step of PIC assembly has also proved amenable to x-ray
crystallographic study. The structure of a TFIIB-TBP-TATA element
ternary complex was reported in 1995 (20) (Fig. 2A). C terminal or core TFIIB (cTFIIB) is a two domain The cTFIIB-TBP-DNA ternary complex is formed by cTFIIB
clamping the acidic C-terminal stirrup of TBP in its basic cleft, and interacting with the phosphoribose backbone upstream and downstream of
the center of the TATA element. The first domain of cTFIIB forms the
downstream surface of the cTFIIB-TBP-DNA ternary complex, where
together with the N-terminal domain of TFIIB (24) (illustrated in Fig.
2B) it could readily act as a bridge between TBP and
pol II to fix the transcription start site. The remaining
solvent-accessible surfaces of TBP and the TFIIB are extensive,
providing ample recognition sites for binding of TAFIIs,
other class II initiation factors, and transcriptional activators and
coactivators. The structure of the TBP-TATA element complex itself is
essentially unchanged by ternary complex formation. cTFIIB
recognizes the preassembled TBP-DNA complex, including the path of the
phosphoribose backbone created by the unprecedented DNA deformation
induced by binding of TBP. In addition to stabilizing the TBP-DNA
complex, TFIIB binding may contribute to the polarity of TATA element
recognition. If TBP were to bind to the quasisymmetric TATA box in the
wrong orientation (i.e., if the N-terminal half of the molecular saddle were to interact with the 5 The solution NMR structure of cTFIIB alone has also been determined
(Fig. 2B) (23). Although each domain in the NMR
structure is very similar to its counterpart in the x-ray structure,
the two structures demonstrate a different spatial arrangement of the
two domains. These data suggest that the oligopeptide linker between
the two domains is flexible, and that TFIIB undergoes a conformational
change on recognizing the preformed TBP-DNA complex. Thus, TFIIB, like
TBP, recognizes its target via induced fit (G. Patikoglou, J. L. Kim,
and S.K.B., unpublished data).
Transcription Factors IIE, -IIF, and -IIH
After formation of the TFIIB-TFIID-DNA complex, three other
general initiation factors and pol II complete the growing PIC. TFIIF
is a heterodimer of subunits with masses of 30 and 74 kDa (reviewed in
ref. 43). Among the general initiation factors, TFIIF is unique in its
ability to form a very stable complex with pol II, referred to as
pol/F (Fig. 1). Although there is no high-resolution structural
information available for TFIIF, the results of site-directed mutagenesis and protein-DNA crosslinking studies provide some information about its location within the PIC. Alanine-scanning mutagenesis of human TBP revealed a single residue essential for TFIIF
binding, which is located on the convex upper surface of the molecular
saddle on its downstream face (44). Photocrosslinking studies
identified crosslinks between both TFIIF subunits and positions The PIC assembly steps detailed above were established in
vitro using the minimal transcription system depicted in Fig.
1B Upper. They are not necessarily the only means by
which a functional PIC can be assembled. Recently, a number of large
multiprotein complexes containing pol II and most of the general
initiation factors (other than TFIID and TFIIB), plus the SRB complex
and other proteins have been purified from nuclear extract (reviewed in
ref. 49). Such complexes are commonly referred to as "pol II
holoenzymes," which is not strictly correct because they cannot function alone. These exciting discoveries suggest that in
vivo the PIC could be assembled in only a few steps (e.g., TFIID
plus DNA, followed by addition of TFIIB and then the "pol II
holoenzyme," as depicted in Fig. 1B).
Cycling of RNA Pol II Transcription Initiation
Once PIC assembly is complete, and in the presence of nucleoside
triphosphates, strand separation at the transcription start site occurs
to give an open complex, the C-terminal domain of the large subunit of
pol II is phosphorylated (presumably by the kinase subunit of TFIIH),
and pol II initiates transcription and is released from the promoter.
During elongation in vitro, TFIID can remain bound to the
core promoter supporting reinitiation of transcription by pol II and
the other general initiation factors (Fig. 1A;
reviewed in ref. 5). Because core promoter binding by the TBP subunit
of TFIID is an intrinsically slow step, the transcription cycle
illustrated in Fig. 1A may represent the mechanism of pol II initiation in vivo. Both the need for chromatin
remodeling, which requires ATP, and the slow isomerization step during
TBP-induced DNA deformation would be amortized over multiple initiation
events if TFIID remained stably associated with the core promoter
between successive rounds of transcription. This scenario is
particularly attractive in the context of an abbreviated PIC assembly
mechanism involving the "pol II holoenzyme."
Regulation of RNA Pol II Transcription Initiation
Regulation of transcription from a class II nuclear gene in
response to developmental or environmental signals is achieved by
controlling assembly of the PIC or the catalytic efficiency of pol II
during initiation, elongation, or termination. When transcriptional
activators interact with TAFIIs, increased recruitment and/or stabilization of TFIID on the promoter is observed (reviewed in ref. 8). The results of studies with hybrid proteins consisting of
TBP fused with heterologous DNA-binding domains suggest that TFIID
recruitment to the promoter can be a rate limiting step (50-52), which
is overcome by activator-TAFII interactions. In vivo footprinting of the promoter proximal regions of some
liver-specific genes have demonstrated that many transcriptional
activators appear to be bound simultaneously (53), which is consistent
with the view that two or more activators can exert synergistic effects on transcription through concerted interactions with multiple components of the PIC. Tjian and coworkers (54, 55) have recently provided direct support for this hypothesis by demonstrating that synergy between two different activators (Bicoid and Hunchback) bound
to the same promoter results, at least in part, from specific interactions with two distinct Drosophila TAFIIs
that enhance TFIID recruitment.
In their simplest form, protein-protein interactions that regulate pol
II activity involve components of the preinitiation complex (TBP,
TAFIIs, TFIIB, pol II, TFIIF, TFIIE, and TFIIH) and
transcriptional activators (bound either to promoter proximal or distal
enhancer elements). Our current picture of activator-TFIID interactions suggests that the TAFIIs can be regarded as a
large multiprotein complex that sits atop TBP and integrates signals from many activators and non-TAFII coactivators. The
remaining general initiation factors and pol II represent distinct
targets within the PIC for interactions with transcriptional
activators. Indeed, it seems likely that every component of the PIC is
the target of at least one transcriptional activator during
transcription from one or more of the estimated 100,000 class II
nuclear gene promoters. Indirect interactions between the PIC and
transcriptional activators mediated by non-TAFII
coactivators have also been observed (Fig. 1B).
Coactivators, such as human PC4, human OCA-B, and the yeast SRB
complex, can serve as adaptors between activators and basal factors
(reviewed in ref. 8).
Transcription Factor IIA
TFIIA was first described as a general initiation factor (7) and
was originally thought to be essential for transcription from many if
not all class II nuclear gene promoters. Following extensive
mechanistic characterization and cloning of the genes encoding the
subunits of TFIIA, however, it is now clear that TFIIA is best defined
as a coactivator that supports regulation of pol II transcription
(reviewed in ref. 3). Early in PIC assembly, TFIIA can associate with
and stabilize the TFIID-DNA or the TFIIB-TFIID-DNA complexes,
allowing them to ward off the deleterious effects of inhibitory
negative cofactors and enhance the stimulatory effects of
transcriptional activators (reviewed in ref. 56).
Recently, the structure of a TFIIA-TBP-TATA element ternary complex
has been determined by x-ray crystallography (21, 22) (Fig.
2A). Yeast TFIIA consists of two When the structures of the cTFIIB-TBP-DNA and TFIIA-TBP-DNA
complexes are combined to create a model of the TFIIA-TFIIB-TBP-DNA quaternary complex (Fig. 3), the mechanism by
which TFIIB and TFIIA act synergistically in stabilizing the TFIID-DNA
complex can be rationalized. Instead of interacting with one another
directly, the basic surfaces of TFIIB and TFIIA make contacts with the
negatively charged phosphoribose backbone on opposite faces of the
double helix immediately upstream of the TATA element. The model of the TFIIA-TFIIB-TBP-DNA complex also provides critical insights into the
role TFIIA as a coactivator, or bridge between transcriptional activators and the PIC. Both subunits of TFIIA form the upstream surface of the TFIIA-TBP-DNA ternary complex, where they are
available for interactions with transcriptional activators bound to
promoter proximal or distal enhancer elements. It is, therefore, not
surprising that the residues on the surface of TBP that are involved in
contacts with TFIIA are essential for activated transcription in
vivo (56, 57).
Conclusions and Perspectives
It has been more that a quarter of a century since the complexity
of eukaryotic transcription was first revealed by Roeder's discovery
of the three RNA polymerases (58). Since then, technically difficult
biochemical work and elegant genetic studies have identified and
functionally characterized many of the components that together facilitate and regulate pol II production of messenger RNA.
Three-dimensional structures of TBP and its complex with the core
promoter, cTFIIB, TFIIBn, and TFIIB-TBP-DNA and TFIIA-TBP-DNA
ternary complexes have revealed novel protein-DNA interactions, and a
detailed mechanistic appreciation of how these polypeptides support
transcription initiation. Structural biologists are now tackling even
larger transcription factor assemblies, and there is every reason to
believe that we will soon see structures of TFIIE, TFIIF, TFIID, TFIIH,
and RNA pol II. Transcription factor biologists are currently directing their efforts toward the problem of understanding how transcription initiation is controlled at the level of an individual gene. There is
considerable evidence that the PIC and transcriptional activators and
coactivators can assemble on a promoter into a stereospecific nucleoprotein complex or "transcriptosome" that supports
transcriptional activation (reviewed in ref. 59).
The other important challenge that must be addressed is the need to
understand the complicated interplay between DNA packaging and
transcription. Unexpectedly, recent crystallographic studies have
documented direct structural connections between transcription factors
and histone proteins (Fig. 4), suggesting that
the macromolecular machines responsible for DNA packaging and
transcription are, at some level, evolutionarily related. The
structural relationships illustrated in Fig. 4 also raise intriguing
questions concerning the mechanisms by which histone-like transcription
factors work (reviewed in ref. 64). TFIID may contain a
TAFII substructure that resembles the histone octamer and
mediates some of TFIID's nonspecific interactions with DNA (11).
Direct evidence of DNA wrapping around TFIID has been obtained by
Roeder and coworkers (65), who demonstrated TAFII-DNA
crosslinks immediately upstream of the TATA element and downstream of
the TATA element extending into the 5
Proc. Natl. Acad. Sci. USA
Vol. 94,
pp. 15-22,
January 1997
Review
, and
§
Howard Hughes
Medical Institute, The Rockefeller University, New York, NY 10021
-factor (reviewed in ref. 6). Promoter
proximal elements occur anywhere between 50 and 200 bp upstream of the
start site and transcriptional activators binding to these sequences
regulate transcription. Finally, distal enhancer elements, which can be
found far from the transcription initiation site in either direction
and orientation, constitute another group of DNA targets for factors
modulating pol II activity.
Factor
Subunits,
kDa
(no.)
Function
TFIID
/TBP
38
(1)
Binds
to TATA, promotes TFIIB binding
\TAFs*
15-250
(12)
Regulatory functions (+ and
)
TFIIB
35
(1)
Promotes TFIIF-pol II binding
TFIIF
30, 74
(2)
Targets pol II to promoter
RNA
pol II
10-220
(12)
Catalytic function
TFIIE
34, 57
(2)
Stimulates TFIIH kinase and ATPase
activities
TFIIH
35-89
(9)
Helicase, ATPase, CTD
kinase activities
All class II GTFs
> 2 MDa
(>42)
Function and subunit composition of the human class II general
initiation factors. The factor denoted with an asterisk is not
absolutely required for in vitro basal or core
promoter-dependent pol II transcription initiation. TBP, TATA
box-binding protein; TAF, TBP-associated factor; GTF, general
transcription factor.
Fig. 1.
(A) PIC assembly begins with TFIID
recognizing the TATA element, followed by coordinated accretion of
TFIIB, the nonphosphorylated form of pol II (pol IIA) plus TFIIF,
TFIIE, and TFIIH. Before elongation pol II is phosphorylated (pol IIO).
Following termination, a phosphatase recycles pol II to its
nonphosphorylated form, allowing the enzyme to reinitiate transcription
in vitro. TBP (and TFIID) binding to the TATA box is an
intrinsically slow step, yielding a long-lived protein-DNA complex.
Efficient reinitiation of transcription can be achieved if recycled pol
II reenters the preinitiation complex before TFIID dissociates from the
core promoter. (Adapted from ref. 5.) (B) Schematic
representation of functional interactions that modulate basal
(Upper) and activator-dependent transcription (Lower). The basal factors TBP, TFIIB, TFIIF, TFIIE, and
TFIIH and pol II are denoted by yellow symbols, with the general
initiation factor contents of a "pol II holoenzyme" enclosed by
square brackets. TAFII and non-TAFII
coactivators (purple) and transcriptional activators (green) are shown
interacting with their targets in the PIC. (Figure courtesy of R. G.
Roeder and S. Stevens, The Rockefeller University.)
[View Larger Version of this Image (31K GIF file)]
Fig. 2.
(A) Three-dimensional structures of
TBP (14-16) (Upper Left), TBP complexed with the TATA
element (17-19) (Upper Right), C terminal or core TFIIB
(cTFIIB)-TBP-TATA element ternary complex (20) (Lower
Left), and TFIIA-TBP-TATA element ternary complex (21, 22)
(Lower Right). The proteins are depicted as ribbon
drawings, with their N and C termini labeled when visible. The DNA is
shown as a stick figure, with hypothetical, linear, B-form extensions at both ends. The transcription start site of the AdMLP is labeled with
+1. TBP, and the TBP-DNA and cTFIIB-TBP-DNA complexes are shown from
the same vantage point downstream of the transcription start site. The
TFIIA-TBP-DNA complex is viewed from upstream of the TATA element,
looking toward the transcription start site. Molecules are color coded
as follows: red, cTFIIB first repeat; magenta, cTFIIB second repeat;
light blue, TBP N terminus and first repeat; dark blue, TBP second
repeat; green, TFIIA small subunit; yellow, TFIIA large subunit; and
gray, DNA. When TBP recognizes the minor groove of the TATA element,
the DNA is kinked and unwound to present the minor groove edges of the
bases to the underside of the molecular saddle. On cTFIIB or TFIIA
binding to the TBP-DNA complex there is essentially no change in the
structure of the binary complex. (B) Structural details of
TFIIB. The relative orientation of the cTFIIB's two domains in the
free and bound form is completely different. The bound and free cTFIIBs
are drawn with their first domains aligned. The N and C termini of the
protein fragments used in the structural studies are labeled, and the
-helices of each cTFIIB domain are colored in order red, green, blue, yellow, and magenta. A helix present only in the second domain of
cTFIIB in the ternary complex is colored light blue. Structure of
cTFIIB in the cTFIIB-TBP-TATA element ternary complex (20)
(Left). Structure of free cTFIIB (23)
(Center). Structure of the N-terminal, Zn2+
binding region of TFIIB (24) (Right). The Zn atom is
colored in red. The 60 residues between the C terminus of the
Zn2+ binding domain and the N terminus of cTFIIB are
flexible and have not been visualized in high-resolution structural
studies.
[View Larger Version of this Image (93K GIF file)]
-sheet, which provides a large concave surface for minor groove and
backbone contacts with the 8-bp TATA element. The 5
end of standard
B-form DNA enters the underside of the molecular saddle, where TBP
produces an abrupt transition to an unprecedented, partially unwound
form of the right-handed double helix induced by insertion of two
phenylalanine residues into the first T:A base step. Thereafter, the
widened minor groove face of the unwound, smoothly bent DNA is
approximated to the underside of the molecular saddle, permitting direct interactions between protein side chains and the minor groove
edges of the central 6 bp. A second large kink is induced by insertion
of two phenylalanine residues into the base step between the last two
base pairs of the TATA element, and there is a corresponding abrupt
return to B-form DNA. Despite this massive distortion, Watson-Crick
base pairing is preserved throughout, and there appears to be no
helical strain induced in the DNA because partial unwinding has been
compensated for by right-handed supercoiling of the double helix.
1·s
1. Once formed, the TBP-TATA box
complex is very stable and the measured half-life of the yeast
TBP-AdMLP complex in aqueous solution is approximately 2 h (36).
Finally, a novel chemical modification study has demonstrated that core
promoter distortion transiently extends beyond the 3
end of the TATA
element during TBP binding (39).
-helical protein that is a structural homolog of the cell cycle protein cyclin A (41,
42) (Fig. 2B). Despite this remarkable structural
similarity, there is no evidence that TFIIB regulates the activity of
any cyclin-dependent kinase. Moreover, the presence of a
cyclin/cyclin-dependent kinase pair within TFIIH would seem to make
the prospect of TFIIB having cyclin-like behavior unlikely.
end of the TATA element), the
basic/hydrophobic surface of the N-terminal stirrup would make
unfavorable electrostatic interactions with the basic cleft of TFIIB.
5,
15, and
19 (45). Together, these data localize TFIIF within the PIC
to the region of the core promoter between the 3
end of the TATA box
(position
24) and the transcription start site (Fig.
2A). TFIIE is an
2
2
heterotetramer of subunits with masses of 34 and 56 kDa (reviewed in
ref. 46). Photocrosslinking studies identified crosslinks between the
34-kDa TFIIE subunit and positions
2 and
14 (45), which localize
TFIIE to the same portion of the core promoter as TFIIF. TFIIH is a
large multiprotein assembly, consisting of nine subunits that range in
mass from 39 to 89 kDa (reviewed in ref. 47). Unlike the other general initiation factors, TFIIH supports various catalytic activities, including DNA-dependent ATPase, ATP-dependent DNA helicase, and a
serine/threonine kinase that is capable of phosphorylating the C-terminal domain of the large subunit of pol II and is regulated by
the cyclin H subunit. At least two of the TFIIH subunits (ERCC2 and
ERCC3) are also components of the DNA excision repair machinery, which
suggests that the TFIIH multiprotein complex may also participate in
DNA repair (reviewed in ref. 48).
/
subunits of 14 and 32 kDa, which form an intimate heterodimer via a
12-stranded
-barrel structure. The ternary complex is formed by
TFIIA recognizing the N-terminal stirrup of TBP and interacting with
the phosphoribose backbone upstream of the TATA element on the opposite
face of the double helix from cTFIIB (Fig. 2A). As
in the cTFIIB-TBP-DNA complex, TFIIA recognizes the preformed
TBP-DNA complex, explaining TFIID-DNA complex stabilization by TFIIA.
Fig. 3.
Model of the TFIIA-TFIIB-TBP-DNA complex based
on the structures of the cTFIIB-TBP-TATA element (20), and the
TFIIA-TBP-TATA element (21, 22) complexes (see Fig.
2A). The transcription start site is labeled with +1.
The color coding scheme is the same as in Fig. 2A.
(Upper) Viewed along TBP's axis of approximate intramolecular symmetry from above the saddle. (Lower)
Viewed from below the molecular saddle.
[View Larger Version of this Image (115K GIF file)]
untranslated region of the gene,
and TFIID-induced DNA supercoiling of a closed circular plasmid. In
contrast, TBP binding to the same plasmid does not alter the linking
number, because DNA supercoiling by TBP is compensated for by partial unwinding of the double helix (reviewed in ref. 25). Finally, the
structural similarity of hepatocyte nuclear factor (HNF)-3
and
histone H5 may be functionally significant. HNF-3 binding to two
adjacent, high-affinity sites in the mouse serum albumin gene enhancer
(66) has been shown to induce phasing of the arrangement of nucleosomes
within the enhancer (27).
Fig. 4.
Structural similarities between transcription
factors and histone proteins. (Upper) Heterotetrameric
assembly of the N-terminal portions of two Drosophila
TAFIIs
(dTAFII42/dTAFII62)2 (60), and
the corresponding view of the histone H3/H4 heterotetramer derived
from the structure of the histone octamer (61) (the additional
N-terminal helix of H3 visualized in this study has been omitted for
clarity). (Lower) The DNA binding domain of hepatocyte nuclear factor-3
(62), and the corresponding view of the globular domain of the linker histone H5 (GH5) (63).
[View Larger Version of this Image (106K GIF file)]
Present address: Cellular Biochemistry and Biophysic
Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
We thank Drs. G. Arents, S. Bagby, J. Geiger, M. Ikura, J. L. Kim, E. N. Moudrianakis, P. B. Sigler, M. Summers, and X. Xie for help with figure preparation. This work was supported by the Howard Hughes Medical Institute (S.K.B.) and a Rockefeller University Graduate Fellowship (D.B.N.).
| 1. | Sentenac, A. (1985) CRC Crit. Rev. Biochem. 18, 31-90 [ISI][Medline] . |
| 2. | Roeder, R. G. (1991) Trends Biochem. Sci. 16, 402-408 [CrossRef][ISI][Medline] . |
| 3. | Zawel, L. & Reinberg, D. (1993) Prog. Nucleic Acid Res. Mol. Biol. 44, 67-108 [ISI][Medline] . |
| 4. | Hori, R. & Carey, M. (1994) Curr. Opin. Genet. Dev. 4, 236-244 [CrossRef][Medline] . |
| 5. |
Zawel, L., Kumar, K. & Reinberg, D.
(1995)
Genes Dev.
9,
1479-1490
|
| 6. | Helmann, J. & Chamberlin, M. (1988) Annu. Rev. Biochem. 57, 839-872 [CrossRef][ISI][Medline] . |
| 7. |
Matsui, T., Segall, J., Weil, P. & Roeder, R.
(1980)
J. Biol. Chem.
255,
11992-11996
|
| 8. | Burley, S. K. & Roeder, R. G. (1996) Annu. Rev. Biochem. 65, 769-799 [CrossRef][ISI][Medline] . |
| 9. | Reese, J., Apone, L., Walker, S., Griffin, L. & Green, M. (1994) Nature (London) 371, 523-527 [CrossRef][Medline] . |
| 10. |
Poon, D., Bai, Y., Campbell, A., Bjorklund, S., Kim, Y.-J., Zhou, S., Kornberg, R. & Weil, P.
(1995)
Proc. Natl. Acad. Sci. USA
92,
8224-8228
|
| 11. | Sawadogo, M. & Roeder, R. G. (1985) Cell 43, 165-175 [CrossRef][ISI][Medline] . |
| 12. | Owen-Hughes, T. & Workman, J. (1994) Crit. Rev. Eukaryotic Gene Expression 4, 403-441 [Medline] . |
| 13. | Peterson, C. L. & Tamkun, J. W. (1995) Trends Biochem. Sci. 20, 143-146 [CrossRef][ISI][Medline] . |
| 14. | Nikolov, D. B. & Burley, S. K. (1994) Nat. Struct. Biol. 1, 621-637 [CrossRef][ISI][Medline] . |
| 15. | Nikolov, D. B., Hu, S.-H., Lin, J., Gasch, A., Hoffmann, A., Horikoshi, M., Chua, N.-H., Roeder, R. G. & Burley, S. K. (1992) Nature (London) 360, 40-46 [CrossRef][Medline] . |
| 16. |
Chasman, D., Flaherty, K., Sharp, P. & Kornberg, R.
(1993)
Proc. Natl. Acad. Sci. USA
90,
8174-8178
|
| 17. | Kim, J. L., Nikolov, D. B. & Burley, S. K. (1993) Nature (London) 365, 520-527 [CrossRef][Medline] . |
| 18. | Kim, Y., Geiger, J. H., Hahn, S. & Sigler, P. B. (1993) Nature (London) 365, 512-520 [CrossRef][Medline] . |
| 19. | Nikolov, D. B., Chen, H., Halay, E. D., Hoffmann, A., Roeder, R. G. & Burley, S. K. (1996) Proc. Natl. Acad. Sci. USA 93, 4956-4961 . |
| 20. | Nikolov, D. B., Chen, H., Halay, E., Usheva, A., Hisatake, K., Lee, D., Roeder, R. G. & Burley, S. K. (1995) Nature (London) 377, 119-128 [CrossRef][Medline] . |
| 21. | Tan, S., Hunziker, Y., Sargent, D. F. & Richmond, T. J. (1996) Nature (London) 381, 127-134 [CrossRef][Medline] . |
| 22. | Geiger, J. H., Hahn, S., Lee, S. & Sigler, P. B. (1996) Science 272, 830-836 [Abstract]. |
| 23. | Bagby, S., Kim, S., Maldonado, E., Tong, K., Reinberg, D. & Ikura, M. (1995) Cell 82, 857-867 [CrossRef][ISI][Medline] . |
| 24. | Zhu, W. L., Zeng, Q. D., Colangelo, C. M., Lewis, L. M., Summers, M. F. & Scott, R. A. (1995) Nat. Struct. Biol. 3, 122-124 . |
| 25. | Kim, J. L. & Burley, S. K. (1994) Nat. Struct. Biol. 1, 638-653 [CrossRef][ISI][Medline] . |
| 26. |
Koshland, D. E., Jr.
(1958)
Proc. Natl. Acad. Sci. USA
44,
98-114
|
| 27. | McPherson, C., Shin, E.-Y., Friedman, D. & Zaret, K. (1993) Cell 75, 387-398 [CrossRef][ISI][Medline] . |
| 28. | Drew, H. & Travers, A. (1985) J. Mol. Biol. 186, 773-790 [CrossRef][ISI][Medline] . |
| 29. | Satchwell, S., Drew, H. & Travers, A. (1986) J. Mol. Biol. 191, 659-679 [CrossRef][ISI][Medline] . |
| 30. | Workman, J. L. & Roeder, R. G. (1987) Cell 51, 613-622 [CrossRef][ISI][Medline] . |
| 31. |
Meisterernst, M., Horikoshi, M. & Roeder, R. G.
(1990)
Proc. Natl. Acad. Sci. USA
87,
9153-9157
|
| 32. | Wolffe, A. (1994) Curr. Opin. Genet. Dev. 4, 245-254 [CrossRef][Medline] . |
| 33. |
Wong, J. & Bateman, E.
(1994)
Nucleic Acids Res.
22,
1890-1896
|
| 34. | Starr, D., Hoopes, B. & Hawley, D. (1995) J. Mol. Biol. 250, 434-446 [CrossRef][ISI][Medline] . |
| 35. | Parvin, J., McCormick, R., Sharp, P. & Fisher, D. (1995) Nature (London) 273, 724-727 . |
| 36. |
Hoopes, B., LeBlanc, J. & Hawley, D.
(1992)
J. Biol. Chem.
267,
11539-11546
|
| 37. | Perez-Howard, G., Weil, P. & Beechem, J. (1995) Biochemistry 34, 8005-8017 [CrossRef][Medline] . |
| 38. | Parkhurst, K., Brenowitz, M. & Parkhurst, L. (1996) Biochemistry 35, 7459-7465 [CrossRef][Medline] . |
| 39. | Sun, D. & Hurley, L. (1995) Chem. Biol. 2, 457-469 [CrossRef][Medline] . |
| 40. | Parvin, J. & Sharp, P. (1993) Cell 73, 533-540 [CrossRef][ISI][Medline] . |
| 41. | Jeffrey, P., Russo, A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J. & Pavletich, N. (1995) Nature (London) 376, 313-320 [CrossRef][Medline] . |
| 42. | Brown, N., Noble, M., Endicott, J., Garman, E., Wakatsuki, S., Mitchell, E., Rasmussen, B., Hunt, T. & Johnson, L. (1995) Structure (London) 3, 1235-1247 [Medline] . |
| 43. |
Tan, S., Conaway, R. C. & Conaway, J. W.
(1995)
Proc. Natl. Acad. Sci. USA
92,
6042-6046
|
| 44. |
Tang, H., Sun, X., Reinberg, D. & Ebright, R. H.
(1996)
Proc. Natl. Acad. Sci. USA
93,
1119-1124
|
| 45. |
Robert, F., Forget, D., Li, J., Greenblatt, J. & Coulombe, B.
(1996)
J. Biol. Chem.
271,
8517-8520
|
| 46. | Okhuma, Y. & Roeder, R. G. (1994) Nature (London) 368, 160-163 [CrossRef][Medline] . |
| 47. | Drapkin, R. & Reinberg, D. (1994) Trends Biochem. Sci. 19, 504-508 [CrossRef][ISI][Medline] . |
| 48. | Svejstrup, J. Q., Wang, Z., Feaver, W. J., Wu, X., Bushnell, D. A., Donahue, T. F., Frieberg, E. C. & Kornberg, R. D. (1995) Cell 80, 21-28 [CrossRef][ISI][Medline] . |
| 49. | Koleske, A. & Young, R. (1995) Trends Biochem. Sci. 20, 113-116 [CrossRef][ISI][Medline] . |
| 50. | Chatterjee, S. & Struhl, K. (1995) Nature (London) 374, 820-822 [CrossRef][Medline] . |
| 51. | Klages, N. & Strubin, M. (1995) Nature (London) 374, 822-824 [CrossRef][Medline] . |
| 52. | Xiao, H., Friesen, J. & Lis, J. (1995) Mol. Cell. Biol. 15, 5757-5761 [Abstract]. |
| 53. | Rigaud, G., Roux, J., Pictet, R. & Grange, T. (1991) Cell 67, 977-986 [CrossRef][ISI][Medline] . |
| 54. |
Sauer, F., Hansen, S. & Tjian, R.
(1995A)
Science
270,
1783-1788
|
| 55. |
Sauer, F., Hansen, S. & Tjian, R.
(1995B)
Science
270,
1825-1828
|
| 56. |
Bryant, G. O., Martel, L., Burley, S. K. & Berk, A. J.
(1996)
Genes Dev.
10,
2491-2504
|
| 57. |
Stargell, L. A. & Struhl, K.
(1995)
Science
269,
75-78
|
| 58. | Roeder, R. G. & Rutter, W. J. (1969) Nature (London) 224, 234-237 [CrossRef][Medline] . |
| 59. | Tjian, R. & Maniatis, T. (1994) Cell 77, 5-8 [CrossRef][ISI][Medline] . |
| 60. | Xie, X., Kokubo, T., Cohen, S. L., Hoffmann, A., Chait, B. T., Roeder, R. G., Nakatani, Y. & Burley, S. K. (1996) Nature (London) 380, 316-322 [CrossRef][Medline] . |
| 61. |
Arents, G., Burlingame, R. W., Wang, B.-C., Love, W. E. & Moudrianakis, E. N.
(1991)
Proc. Natl. Acad. Sci. USA
88,
10148-10152
|
| 62. | Clark, K. L., Halay, E. D., Lai, E. & Burley, S. K. (1993) Nature (London) 364, 412-420 [CrossRef][Medline] . |
| 63. | Ramakrishnan, V., Finch, J., Graziano, V. & Sweet, R. (1993) Nature (London) 362, 219-223 [CrossRef][Medline] . |
| 64. | Burley, S. K., Xie, X., Clark, K. L. & Shu, F. (1997) Curr. Opin. Struct. Biol. 7, in press. |
| 65. | Oelgeschlager, T., Chiang, C.-M. & Roeder, R. G. (1996) Nature (London) 382, 735-738 [CrossRef][Medline] . |
| 66. |
Liu, J.-K., DiPersio, C. M. & Zaret, K. S.
(1991)
Mol. Cell. Biol.
11,
773-784
|
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
S. Akashi, S. Nagakura, S. Yamamoto, M. Okuda, Y. Ohkuma, and Y. Nishimura Structural characterization of human general transcription factor TFIIF in solution Protein Sci., March 1, 2008; 17(3): 389 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Glenn, J. R. Beattie, L. Barrett, N. Frizzell, S. R. Thorpe, M. E Boulton, J. J. McGarvey, and A. W. Stitt Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging FASEB J, November 1, 2007; 21(13): 3542 - 3552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panebra, M. R. Schwarb, C. B. Glinka, and S. B. Liggett Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L453 - L462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. D. Zhang, A. Paccanaro, Y. Fu, S. Weissman, Z. Weng, J. Chang, M. Snyder, and M. B. Gerstein Statistical analysis of the genomic distribution and correlation of regulatory elements in the ENCODE regions Genome Res., June 1, 2007; 17(6): 787 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Su, D. Lee, B. Ganss, and J. Sodek Stereochemical Analysis of the Functional Significance of the Conserved Inverted CCAAT and TATA Elements in the Rat Bone Sialoprotein Gene Promoter J. Biol. Chem., April 14, 2006; 281(15): 9882 - 9890. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. STITT The Maillard Reaction in Eye Diseases Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 582 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Gershenzon and I. P. Ioshikhes Synergy of human Pol II core promoter elements revealed by statistical sequence analysis Bioinformatics, April 15, 2005; 21(8): 1295 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Tsai, H.-C. Wang, J.-H. Leu, H.-H. Hsiao, A. H.-J. Wang, G.-H. Kou, and C.-F. Lo Genomic and Proteomic Analysis of Thirty-Nine Structural Proteins of Shrimp White Spot Syndrome Virus J. Virol., October 15, 2004; 78(20): 11360 - 11370. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Eriksson, D. Biswas, Y. Yu, J. M. Stewart, and D. J. Stillman TATA-Binding Protein Mutants That Are Lethal in the Absence of the Nhp6 High-Mobility-Group Protein Mol. Cell. Biol., July 15, 2004; 24(14): 6419 - 6429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vigneault, S. McGraw, L. Massicotte, and M.-A. Sirard Transcription Factor Expression Patterns in Bovine In Vitro-Derived Embryos Priorto Maternal-Zygotic Transition Biol Reprod, June 1, 2004; 70(6): 1701 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monslow, J. D. Williams, C. A. Guy, I. K. Price, K. J. Craig, H. J. Williams, N. M. Williams, J. Martin, S. L. Coleman, N. Topley, et al. Identification and Analysis of the Promoter Region of the Human Hyaluronan Synthase 2 Gene J. Biol. Chem., May 14, 2004; 279(20): 20576 - 20581. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Hartman and P. Hentosh The Antileukemia Drug 2-Chloro-2'-deoxyadenosine: An Intrinsic Transcriptional Antagonist Mol. Pharmacol., January 1, 2004; 65(1): 227 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rombauts, K. Florquin, M. Lescot, K. Marchal, P. Rouze, and Y. Van de Peer Computational Approaches to Identify Promoters and cis-Regulatory Elements in Plant Genomes Plant Physiology, July 1, 2003; 132(3): 1162 - 1176. [Abstract] [Full Text] [PDF] |
||||